EP547
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EP547, covering 2023-06-12 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis [Phase 2]